semaglutide and iih Idiopathic Intracranial Hypertension After Abrupt Cessation of Medication: A Case Report of Abrupt Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Cessation Review of the Literature Semaglutide as an Adjunctive Therapy

The Precision Peptide test ($99 add-on after your first month of treatment) identifies these patterns so your PlexusDx provider can adjust your therapy proactively

How Semaglutide Works for Weight Loss and Metabolic Health Semaglutide is a GLP-1 receptor agonist that mimics glucagon-like peptide-1, a naturally occurring hormone central to appetite regulation, insulin secretion, and gastric motility

Another area relevant to the GLP-1cocaine link is the lateral septum, which exhibits the highest level of expression of GLP-1R in the brain and modulates the activity within the mesolimbic system

27 Consistent with these findings, a large global retrospective cohort study involving over 5 million individuals with obesity across 17 countries supported the neuroprotective potential of semaglutide in people with obesity, revealing reduced rates of AD (relative risk [RR] of 0.627), Lewy body dementia (RR of 0.59), vascular dementia (RR of 0.438), and PD (RR of 0.574)

Responsive Support Clear communication and timely assistance when you need it

Staying hydrated and avoiding high-fat foods immediately after injection further reduces gastrointestinal discomfort, making nausea manageable within the first 1 to 2 weeks